Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Granisetron manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

granisetron

Injection 1 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #7738
A pharmaceutical manufacturer specialised in both active pharmaceutical ingredients (APIs) and finished dosage pharmaceutical products, with capabilities spanning complex technologies (such as polysaccharides) and advanced intermediate manufacturing. The company’s facilities are certified by major regulatory authorities including US FDA inspection, EU-GMP certification, WHO-GMP certification, plus approvals from COFEPRIS (Mexico) and the Korean MFDS, supporting global supply to multiple regions worldwide.

Manufacturer usually replies in 6 days

granisetron

Vials, injection 1 mg/ml - 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #18885
This company is a leading pharmaceutical formulations manufacturer with over 30 years of experience. They specialize in injectable medications, particularly hormones and β-lactam antibiotics, for both human and veterinary use. Their product portfolio includes analgesics, antibacterials, antivirals, cardiovascular drugs, and gastrointestinal products among others. They hold GMP certifications and operate a state-of-the-art manufacturing facility adhering to ISO 9001:2015 standards. The company focuses on providing high-quality medications at affordable prices across the EU and North America.

Manufacturer usually replies in 4 days

granisetron

Solution for injection 1mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United States , Canada , Denmark , Sweden , Norway , Finland , Belgium , Netherlands , Luxembourg , Portugal
Manufacturer #15146
This company has been operating for nearly a century and is a global leader in the healthcare industry. It specializes in providing a wide range of products and solutions for patients and healthcare professionals. Their offerings include medical devices, pharmaceutical products, and nutritional care solutions. The company is known for its commitment to innovation and its dedication to improving patient outcomes. Their primary therapy areas include kidney care, nutritional care, and respiratory care. They produce a variety of dosage forms including injectables, liquids, and solids. They have obtained EU and USA GMP approvals for many of their production lines. Their products have a strong track record in the industry. They have a global presence, with key export markets in North America and the EU.

Manufacturer usually replies in 13 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Granisetron Manufacturers

Markets of interest

Granisetron is an antiemetic and antinauseant for cancer chemotherapy patients. As a serotonin receptor (5HT-3 selective) antagonist that has been used the substance blocks the actions of chemicals in the body that can trigger nausea and vomiting. The medication is used to prevent nausea and vomiting that may be caused by medicine to treat cancer (chemotherapy or radiation). The substance is available for sale in the form of ampoules, tablets, film-coated, tablets, vials, solution for infusion, solution for injection/infusion, from manufacturers in various countries including Y. The drug is provided by a wide range of Granisetron suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Granisetron manufacturers and distributors are based in India, China, and Turkey.

Licensing and brand names

Granisetron was approved by the FDA for use in the USA in 2020. In 2011 under the trade name Kytril, the medication was approved by the EMA in the European Union. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Granisetron Hydrochloride, Kytril. One of the most popular branded versions of Granisetron is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from China, India, South Korea, Spain, Malta, Taiwan, and the United States, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Granisetron as an active ingredient.

Target supply price

The wholesale acquisition cost for granisetron intravenous solution (1 mg/mL) is around $18 for a supply of 1 milliliter(s). The retail price of 10 film-coated tablets (1Mg/film-coated tablet) of the substance in Europe reaches 30.74 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Granisetron manufacturers and suppliers that you are looking for. You can also find the dossier status of Granisetron and the GMP approvals of the different variants of the medication. The product description of all Granisetron suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Granisetron is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.